ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
10x Genomics Inc

10x Genomics Inc (TXG)

39,095
0,045
( 0,12% )
Aktualisiert: 18:59:05

10x Genomics Inc (TXG) Aktie

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
39,095
( 0,12% )
Gebot
39,04
Fragen
39,15
Volumen
1.032.887
38,37 Tagesbereich 39,83
11,16 52-Wochen-Bereich 40,08
Marktkapitalisierung
Handelsende
39,05
Handelsbeginn
39,28
Letzte Trade
1
@
39.095
Letzter Handelszeitpunkt
18:59:18
Finanzvolumen
US$ 40.393.202
VWAP
39,1071
Durchschnittliches Volumen (3 Mio.)
US$ 3.000.309
Ausgegebene Aktien
126.956.189
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-204,66
Gewinn pro Aktie (EPS)
-0,18
Erlöse (LTM)
638,78M
Nettogewinn (LTM)
-22,66M

Über 10x Genomics Inc

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enabl... 10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3’ gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides. In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents. Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns. The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Hauptsitz
Pleasanton, United States
Gegründet
2026
10x Genomics Inc is listed in the Healthcare sector of the NASDAQ with ticker TXG. The last closing price for 10x Genomics was US$39,05. Over the last year, 10x Genomics shares have traded in a share price range of US$ 11,16 to US$ 40,08.

10x Genomics currently has 126.956.189 shares in issue. The market capitalisation of 10x Genomics is US$4,96 billion. 10x Genomics has a price to earnings ratio (PE ratio) of -204.66.

TXG Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
14.613.335265980634.49540.0834.495420689237.22776235CS
46.7220.756756756832.37540.0828.01366222333.37904916CS
1216.21570.869755244822.8840.0819.5301308900927.53043734CS
2622.765139.40600122516.3340.0815.9279380023.9112069CS
5227.025223.90223695112.0740.0811.16277176018.96205035CS
156-17.095-30.423562911656.1963.576.78225419920.28419426CS
260-152.495-79.5944464742191.59197.096.78178706931.69110037CS

TXG - Frequently Asked Questions (FAQ)

What is the current 10x Genomics Inc share price?
The current share price of 10x Genomics Inc is US$ 39,095
How many 10x Genomics Inc shares are in issue?
10x Genomics Inc has 126.956.189 shares in issue
What is the market cap of 10x Genomics Inc?
The market capitalisation of 10x Genomics Inc is USD 4,96B
What is the 1 year trading range for 10x Genomics Inc share price?
10x Genomics Inc has traded in the range of US$ 11,16 to US$ 40,08 during the past year
What is the PE ratio of 10x Genomics Inc?
The price to earnings ratio of 10x Genomics Inc is -204,66
What is the cash to sales ratio of 10x Genomics Inc?
The cash to sales ratio of 10x Genomics Inc is 7,3
What is the registered address of 10x Genomics Inc?
The registered address for 10x Genomics Inc is 6230 Stoneridge Mall Road, Pleasanton, California, 94588-3260
What is the 10x Genomics Inc website address?
The website address for 10x Genomics Inc is www.10xgenomics.com
Which industry sector does 10x Genomics Inc operate in?
10x Genomics Inc operates in the Biotechnology & Life Sciences sector

TXG Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen